FindTrial
Sign In

A study to see the effectiveness of acetazolamide in healthy people travelling to mountains

Response of unacclimatized healthy lowlanders under pharmaco-prophylaxis for acute mountain sickness to sub-maximal exercise at 3500m

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/12/010865
Enrollment
101
Registered
2017-12-13
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Placebo: Participants of other arm were given Dextrose in similar looking capsules once daily starting 12 hours before boarding flight from Chandigarh for Leh. Intervention2: Acetazolam

Sponsors

Director General Armed Forces Medical Services
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Healthy males with no history of visit to high altitude in last 3 years.

Exclusion criteria

Exclusion criteria: Known history of cross reactivity to sulphonamides. Hypertension

Design outcomes

Primary

MeasureTime frame
Incidence of acute mountain sicknessTimepoint: At sea level and 24 hours after reaching high altitude—

Secondary

MeasureTime frame
Measurement of exercise capacity at high altitudeTimepoint: After 72 hours after reaching high altitude—

Countries

India

Contacts

Public ContactDr Gaurav Sikri

Armed Forces Medical services

drgaurav35@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026